Mindfulness program for people with Parkinson's and their caregivers
Enhancing Psychological Wellbeing and the Patient-caregiver Relationship Through Dyadic Mindfulness: A Randomized Controlled Trial in People With Parkinson's Disease and Their Caregivers
This study tests whether a mindfulness program can help people with Parkinson's and their caregivers feel better emotionally and improve their relationship.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 50 Years to 80 Years |
| Sex | All |
| Sponsor | The University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong) |
| Trial ID | NCT06821230 on ClinicalTrials.gov |
What this trial studies
This trial investigates the effects of dyadic mindfulness on both physical and emotional outcomes for individuals with Parkinson's Disease and their caregivers. One hundred patient-caregiver pairs will be randomly assigned to either participate in eight weekly mindfulness sessions or receive usual care. The study will assess various outcomes, including negative emotions, relationship dynamics, mindfulness levels, quality of life, and caregiving burden. Additionally, in-depth interviews will be conducted with a subset of participants to gather qualitative insights on their experiences with the intervention.
Who should consider this trial
Good fit: Ideal candidates include Chinese individuals aged 50-80 with mild to moderate Parkinson's Disease and their primary caregivers who can communicate in Cantonese.
Not a fit: Patients who regularly engage in supervised mindfulness practices or have significant cognitive impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could improve emotional well-being and quality of life for both patients and their caregivers.
How similar studies have performed: While similar mindfulness interventions have shown promise in other populations, this specific dyadic approach in Parkinson's Disease is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria of PwPD: * Chinese patients with idiopathic mild-moderate PD (as indicated by the Hoehn and Yahr Scale stages I-III: those with unilateral/bilateral symptoms, with/without postural instability who are able to walk/stand unassisted) * Aged 50-80 * Experience at least mild negative emotions (as indicated by the 21-item Depression, Anxiety and Stress Scale \[DASS21\] score of Depression subscale ≥10, Anxiety subscale ≥8, or Stress subscale ≥15) Inclusion Criteria of caregivers of PwPD: \- Self-identified as the primary caregivers of their patient Both need to be able to communicate in Cantonese and provide written consent. Exclusion Criteria: * Engage in regular supervised mind-body practices such as Tai Chi, yoga, or other forms of mindfulness training (\>2 times per week) * Have a pre-existing acute psychotic disease * Currently participating in any other behavioral or pharmacological trial * Have significant cognitive impairment, as indicated by an Abbreviated Mental Test score≤ 6 * Have other contraindications that may limit their full participation (e.g., severe hearing/vision impairment)
Where this trial is running
Hong Kong
- School of Nursing, The University of Hong Kong — Hong Kong, Hong Kong (Recruiting)
Study contacts
- Study coordinator: Jojo Yan Yan Kwok
- Email: jojoyyk@hku.hk
- Phone: 852 39176644
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.